Effectiveness and safety of intravenous iron sucrose in correcting ferritin level for female patients with iron deficiency anemia
1
internal medicine, college of medicine. Kufa university, Iraq
2
internal medicine, Alnajaf teaching hospital, Iraq
3
chemical pathology, college of medicine. Kufa university, Iraq
Submission date: 2024-02-05
Final revision date: 2025-03-17
Acceptance date: 2025-04-08
Publication date: 2025-07-25
Corresponding author
Maysam Riyadh Mohammed Hussein Alaasam
internal medicine, college of medicine. Kufa university, Iraq
internal medicine, college of medicine. Kufa university, Iraq
Wiadomości Lekarskie 2025;(6)
KEYWORDS
TOPICS
ABSTRACT
Aim:
The study aims to evaluate the effectiveness and safety of intravenous iron sucrose in correcting serum ferritin in female patients with iron deficiency anemia.
Material and methods:
A prospective clinical study was conducted at Alsader Medical City in AlNajaf City/ Iraq. We enrolled 100 female patients with iron deficiency anemia, and hemoglobin less than 12 mg/dl. Two hundred mg of elemental iron was given twice weekly over 2.5 hours, and the patients were observed closely for any potential side effects. The main effectiveness endpoint gained from variation in serum ferritin and hemoglobin from baseline to end of the study. The safety evaluation includes recording any side effects developed either during or after intravenous administration.
Results:
The mean of hemoglobin concentration at bassline was 8.05±0.891 mg/dl, and the mean of hemoglobin after one month of treatment was 11.234±1.232G/dl,(p <0.0001). There was an increase in serum ferritin concentration from the beginning of the study with 10.2±0.23ng/dl to 224.12±0.772 ng/dl, (p<0.0001) after 1 month of treatment. No one of the patients had any serious or lethal side effects.
Conclusions:
Intravenous iron sucrose is an effective and safe option for the correction of serum ferritin in female patients with iron deficiency anemia.
The study aims to evaluate the effectiveness and safety of intravenous iron sucrose in correcting serum ferritin in female patients with iron deficiency anemia.
Material and methods:
A prospective clinical study was conducted at Alsader Medical City in AlNajaf City/ Iraq. We enrolled 100 female patients with iron deficiency anemia, and hemoglobin less than 12 mg/dl. Two hundred mg of elemental iron was given twice weekly over 2.5 hours, and the patients were observed closely for any potential side effects. The main effectiveness endpoint gained from variation in serum ferritin and hemoglobin from baseline to end of the study. The safety evaluation includes recording any side effects developed either during or after intravenous administration.
Results:
The mean of hemoglobin concentration at bassline was 8.05±0.891 mg/dl, and the mean of hemoglobin after one month of treatment was 11.234±1.232G/dl,(p <0.0001). There was an increase in serum ferritin concentration from the beginning of the study with 10.2±0.23ng/dl to 224.12±0.772 ng/dl, (p<0.0001) after 1 month of treatment. No one of the patients had any serious or lethal side effects.
Conclusions:
Intravenous iron sucrose is an effective and safe option for the correction of serum ferritin in female patients with iron deficiency anemia.
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
